{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:19:04Z","timestamp":1793319544802,"version":"4.5.0"},"publisher-location":"Singapore","reference-count":141,"publisher":"Springer Singapore","isbn-type":[{"value":"9789811525162","type":"print"},{"value":"9789811525179","type":"electronic"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/978-981-15-2517-9_1","type":"book-chapter","created":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T13:18:26Z","timestamp":1585919906000},"page":"1-36","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":252,"title":["Coronary Artery Disease: From Mechanism to Clinical Practice"],"prefix":"10.1007","author":[{"given":"Chunli","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-da","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,26]]},"reference":[{"key":"1_CR1","unstructured":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) (1996) CAPRIE Steering Committee. Lancet 348:1329\u20131339"},{"key":"1_CR2","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1056\/NEJMoa042741","volume":"353","author":"A Abidov","year":"2005","unstructured":"Abidov A, Rozanski A, Hachamovitch R et al (2005) Prognostic significance of dyspnea in patients referred for cardiac stress testing. N Engl J Med 353:1889","journal-title":"N Engl J Med"},{"key":"1_CR3","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.ijcard.2004.12.014","volume":"104","author":"SZ Abildstrom","year":"2005","unstructured":"Abildstrom SZ, Ottesen MM, Rask-Madsen C, Andersen PK, Rosthoj S, Torp-Pedersen C, Kober L (2005) Sudden cardiovascular death following myocardial infarction: the importance of left ventricular systolic dysfunction and congestive heart failure. Int J Cardiol 104:184\u2013189","journal-title":"Int J Cardiol"},{"key":"1_CR4","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.amjmed.2003.09.038","volume":"116","author":"WK Al-Delaimy","year":"2004","unstructured":"Al-Delaimy WK, Merchant AT, Rimm EB et al (2004) Effect of type 2 diabetes and its duration on the risk of peripheral arterial disease among men. Am J Med 116:236","journal-title":"Am J Med"},{"key":"1_CR5","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1016\/j.jacc.2005.11.073","volume":"47","author":"MH Al-Mallah","year":"2006","unstructured":"Al-Mallah MH, Tleyjeh IM, Abdel-Latif AA et al (2006) Angiotensin-converting enzyme inhibitors in coronary artery disease and preserved left ventricular systolic function: A systematic review and meta-analysis of randomized controlled trials. J Am Coll Cardiol 47:1576","journal-title":"J Am Coll Cardiol"},{"key":"1_CR6","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1001\/archinte.164.13.1422","volume":"164","author":"T Almdal","year":"2004","unstructured":"Almdal T, Scharling H, Jensen JS, Vestergaard H (2004) The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow-up. Arch Intern Med 164:1422","journal-title":"Arch Intern Med"},{"key":"1_CR7","doi-asserted-by":"crossref","unstructured":"Andresdottir MB, Sigurdsson G, Sigvaldason H et al (2002) Fifteen percent of myocardial infarctions and coronary revascularizations explained by family history unrelated to conventional risk factors. The Reykjavik Cohort Study. Eur Heart J 23:1655","DOI":"10.1053\/euhj.2002.3235"},{"key":"1_CR8","unstructured":"Antman EM, Anbe DT, Armstrong PW et al (2006a) ACC\/AHA guidelines for the management of patients with ST-elevation myocardial infarction. \nwww.acc.org\/qualityandscience\/clinical\/statements.htm\n\n. Accessed 24 Aug 2006"},{"key":"1_CR9","unstructured":"Antman EM, Anbe DT, Armstrong PW et al (2006b) ACC\/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. Accessed 19 Apr 2006"},{"key":"1_CR10","doi-asserted-by":"crossref","unstructured":"Antman EM, Morrow DA, McCabe CH, Murphy SA, Ruda M, Sadowski Z, Budaj A, Lopez-Sendon JL, Guneri S, Jiang F, White HD, Fox KA, Braunwald E (2006c) Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction. N Engl J Med 354:1477\u20131488","DOI":"10.1056\/NEJMoa060898"},{"key":"1_CR11","doi-asserted-by":"crossref","unstructured":"Asia Pacific Cohort Studies Collaboration (2005) Joint effects of systolic blood pressure and serum cholesterol on cardiovascular disease in the Asia Pacific region. Circulation 112:3384","DOI":"10.1161\/CIRCULATIONAHA.105.537472"},{"key":"1_CR12","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1001\/jama.294.4.448","volume":"294","author":"A Babaev","year":"2005","unstructured":"Babaev A, Frederick PD, Pasta DJ, Every N, Sichrovsky T, Hochman JS (2005) Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. JAMA 294:448\u2013454","journal-title":"JAMA"},{"key":"1_CR13","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.jacc.2007.04.060","volume":"50","author":"S Bangalore","year":"2007","unstructured":"Bangalore S, Messerli FH, Kostis JB et al (2007) Cardiovascular protection using beta-blockers: a critical review of the evidence. J Am Coll Cardiol 50:563","journal-title":"J Am Coll Cardiol"},{"key":"1_CR14","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.1540-8175.1999.tb00817.x","volume":"16","author":"S Barbera","year":"1999","unstructured":"Barbera S, Hillis LD (1999) Echocardiographic recognition of left ventricular mural thrombus. Echocardiography 16:289\u2013295","journal-title":"Echocardiography"},{"key":"1_CR15","doi-asserted-by":"publisher","first-page":"e001354","DOI":"10.1161\/JAHA.112.001354","volume":"1","author":"CE Barlow","year":"2012","unstructured":"Barlow CE, Defina LF, Radford NB et al (2012) Cardiorespiratory fitness and long-term survival in \u201clow-risk\u201d adults. J Am Heart Assoc 1:e001354","journal-title":"J Am Heart Assoc"},{"key":"1_CR16","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1056\/NEJMoa064278","volume":"357","author":"P Barter","year":"2007","unstructured":"Barter P, Gotto AM, LaRosa JC et al (2007) HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N Engl J Med 357:1301","journal-title":"N Engl J Med"},{"key":"1_CR17","doi-asserted-by":"publisher","first-page":"381","DOI":"10.2310\/6650.2001.33783","volume":"49","author":"IJ Benjamin","year":"2001","unstructured":"Benjamin IJ (2001) Matrix metalloproteinases: from biology to therapeutic strategies in cardiovascular disease. J Investig Med 49:381\u2013397","journal-title":"J Investig Med"},{"key":"1_CR18","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1749-6632.2001.tb03932.x","volume":"947","author":"BC Berk","year":"2001","unstructured":"Berk BC, Abe JI, Min W et al (2001) Endothelial atheroprotective and anti-inflammatory mechanisms. Ann N Y Acad Sci 947:93\u2013109","journal-title":"Ann N Y Acad Sci"},{"key":"1_CR19","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1016\/j.jacc.2007.03.025","volume":"49","author":"DL Bhatt","year":"2007","unstructured":"Bhatt DL, Flather MD, Hacke W et al (2007) Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial. J Am Coll Cardiol 49:1982","journal-title":"J Am Coll Cardiol"},{"key":"1_CR20","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1136\/pmj.79.935.490","volume":"79","author":"Y Birnbaum","year":"2003","unstructured":"Birnbaum Y, Drew BJ (2003) The electrocardiogram in ST elevation acute myocardial infarction: correlation with coronary anatomy and prognosis. Postgrad Med J 79:490\u2013504","journal-title":"Postgrad Med J"},{"key":"1_CR21","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1056\/NEJMra020228","volume":"347","author":"Y Birnbaum","year":"2002","unstructured":"Birnbaum Y, Fishbein MC, Blanche C, Siegel RJ (2002a) Ventricular septal rupture after acute myocardial infarction. N Engl J Med 347:1426\u20131432","journal-title":"N Engl J Med"},{"key":"1_CR22","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1097\/00019501-200209000-00006","volume":"13","author":"Y Birnbaum","year":"2002","unstructured":"Birnbaum Y, Chamoun AJ, Conti VR, Uretsky BF (2002b) Mitral regurgitation following acute myocardial infarction. Coron Artery Dis 13:337\u2013344","journal-title":"Coron Artery Dis"},{"key":"1_CR23","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1056\/NEJMoa055227","volume":"354","author":"KH Bonaa","year":"2006","unstructured":"Bonaa KH, Njolstad I, Ueland PM et al (2006) Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 354:1578","journal-title":"N Engl J Med"},{"key":"1_CR24","doi-asserted-by":"crossref","unstructured":"Calle EE, Thun MJ, Petrelli JM et al (1999) Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 341:1097","DOI":"10.1056\/NEJM199910073411501"},{"key":"1_CR25","doi-asserted-by":"crossref","unstructured":"Cheitlin MD, Armstrong WF, Aurigemma GP, Beller GA, Bierman FZ, Davis DL, Douglas PS, Faxon DP, Gillam LD, Kimball TR, Kussmaul WG, Pearlman AS, Philbrick JT, Rakowski H, Thys DM (2003) ACC\/AHA\/ASE 2003 guideline update for the clinical application of echocardiography: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (ACC\/AHA\/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). Accessed 19 Apr 2006","DOI":"10.1016\/S0894-7317(03)00685-0"},{"key":"1_CR26","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/S0140-6736(09)60753-4","volume":"373","author":"Z Chen","year":"2009","unstructured":"Chen Z (2009) Launch of the health-care reform plan in China. Lancet 373:1322\u20131324","journal-title":"Lancet"},{"key":"1_CR27","doi-asserted-by":"crossref","unstructured":"Chowdhury R, Warnakula S, Kunutsor S et al (2014) Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and metaanalysis. Ann Intern Med 160:398","DOI":"10.7326\/M13-1788"},{"key":"1_CR28","doi-asserted-by":"crossref","unstructured":"Dauchet L, Amouyel P, Dallongeville J (2005) Fruit and vegetable consumption and risk of stroke: a meta-analysis of cohort studies. Neurology 65:1193","DOI":"10.1212\/01.wnl.0000180600.09719.53"},{"key":"1_CR29","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1161\/01.CIR.94.8.2013","volume":"94","author":"MJ Davies","year":"1996","unstructured":"Davies MJ (1996) Stability and instability: the two faces of coronary atherosclerosis: the Paul Dudley White Lecture 1995. Circulation 94:2013\u20132020","journal-title":"Circulation"},{"key":"1_CR30","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1136\/hrt.69.5.377","volume":"69","author":"MJ Davies","year":"1993","unstructured":"Davies MJ, Richardson PD, Woolf N et al (1993) Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage and smooth muscle cell content. Br Heart J 69:377\u2013381","journal-title":"Br Heart J"},{"key":"1_CR31","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1161\/hc4601.099486","volume":"104","author":"PH Davis","year":"2001","unstructured":"Davis PH, Dawson JD, Riley WA, Lauer RM (2001) Carotid intimal-medial thickness is related to cardiovascular risk factors measured from childhood through middle age: the Muscatine Study. Circulation 104:2815","journal-title":"Circulation"},{"key":"1_CR32","unstructured":"de Souza RJ, Mente A, Maroleanu A et al (2015) Intake of saturated and transunsaturated fatty acids and risk of all cause mortality, cardiovascular disease, and type 2 diabetes: systematic review and meta-analysis of observational studies. BMJ 351:h3978"},{"key":"1_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/eurheartj\/ehi552","volume":"27","author":"A Chiara Di","year":"2006","unstructured":"Di Chiara A (2006) Right bundle branch block during the acute phase of myocardial infarction: modern redefinitions of old concepts. Eur Heart J 27:1\u20132","journal-title":"Eur Heart J"},{"key":"1_CR34","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1161\/01.CIR.98.1.17","volume":"98","author":"JG Diodati","year":"1998","unstructured":"Diodati JG, Dakak N, Gilligan DM et al (1998) Effect of atherosclerosis on endothelium-dependent inhibition of platelet activation in humans. Circulation 98:17\u201324","journal-title":"Circulation"},{"key":"1_CR35","doi-asserted-by":"crossref","unstructured":"Downs JR, Clearfield M, Weis S et al (1998) Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS\/TexCAPS. Air Force\/Texas Coronary Atherosclerosis Prevention Study. JAMA 279:1615","DOI":"10.1001\/jama.279.20.1615"},{"key":"1_CR36","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.1161\/01.CIR.0000140086.88453.9A","volume":"110","author":"RH Eckel","year":"2004","unstructured":"Eckel RH, York DA, R\u00f6ssner S et al (2004) Prevention Conference VII: obesity, a worldwide epidemic related to heart disease and stroke: executive summary. Circulation 110:2968","journal-title":"Circulation"},{"key":"1_CR37","doi-asserted-by":"crossref","unstructured":"Emerging Risk Factors Collaboration, Kaptoge S, Di Angelantonio E et al (2010) C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 375:132","DOI":"10.1016\/S0140-6736(09)61717-7"},{"key":"1_CR38","doi-asserted-by":"crossref","unstructured":"Ergin A, Muntner P, Sherwin R, He J (2004) Secular trends in cardiovascular disease mortality, incidence, and case fatality rates in adults in the United States. Am J Med 117:219","DOI":"10.1016\/j.amjmed.2004.03.017"},{"key":"1_CR39","doi-asserted-by":"publisher","first-page":"901","DOI":"10.3945\/ajcn.111.023648","volume":"95","author":"A Floegel","year":"2012","unstructured":"Floegel A, Pischon T, Bergmann MM et al (2012) Coffee consumption and risk of chronic disease in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Germany study. Am J Clin Nutr 95:901","journal-title":"Am J Clin Nutr"},{"key":"1_CR40","doi-asserted-by":"crossref","unstructured":"Furman MI, Dauerman HL, Goldberg RJ et al (2001) Twenty two year (1975 to 1997) trends in the incidence, in hospital and long term case fatality rates from initial Qwave and non Qwave myocardial infarction: a multihospital, community wide perspective. J Am Coll Cardiol 37:1571","DOI":"10.1016\/S0735-1097(01)01203-7"},{"key":"1_CR41","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1161\/res.90.3.251","volume":"90","author":"ZS Galis","year":"2002","unstructured":"Galis ZS, Khatri JJ (2002) Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res. 90:251\u2013262","journal-title":"Circ Res."},{"key":"1_CR42","doi-asserted-by":"crossref","unstructured":"Gansevoort RT, Correa-Rotter R, Hemmelgarn BR et al (2013) Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet 382:339","DOI":"10.1016\/S0140-6736(13)60595-4"},{"key":"1_CR43","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/S0735-1097(98)00637-8","volume":"33","author":"HC Gerstein","year":"1999","unstructured":"Gerstein HC, Pais P, Pogue J, Yusuf S (1999) Relationship of glucose and insulin levels to the risk of myocardial infarction: a case-control study. J Am Coll Cardiol 33:612","journal-title":"J Am Coll Cardiol"},{"key":"1_CR44","first-page":"357","volume":"6","author":"U Goldbourt","year":"1986","unstructured":"Goldbourt U, Neufeld HN (1986) Genetic aspects of arteriosclerosis. Arter-Scler 6:357\u2013377","journal-title":"Arter-Scler"},{"key":"1_CR45","unstructured":"Goyal A, Yusuf S (2006) The burden of cardiovascular disease in the Indian subcontinent. Indian J Med Res 124:235"},{"key":"1_CR46","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1161\/hq1201.100220","volume":"21","author":"G Hansson","year":"2001","unstructured":"Hansson G (2001) Immune mechanisms in atherosclerosis. Arterioscler Thromb Vasc Biol 21:1876\u20131890","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1_CR47","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1385\/IR:23:2-3:099","volume":"23","author":"J Hawiger","year":"2001","unstructured":"Hawiger J (2001) Innate immunity and inflammation: a transcriptional paradigm. Immunol Res 23:99\u2013109","journal-title":"Immunol Res"},{"key":"1_CR48","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1093\/eurheartj\/ehi147","volume":"26","author":"V Hombach","year":"2005","unstructured":"Hombach V, Grebe O, Merkle N, Waldenmaier S, Hoher M, Kochs M, Wohrle J, Kestler HA (2005) Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging. Eur Heart J 26:549\u2013557","journal-title":"Eur Heart J"},{"key":"1_CR49","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/S0140-6736(05)70240-3","volume":"365","author":"R Jackson","year":"2005","unstructured":"Jackson R, Lawes CM, Bennett DA et al (2005) Treatment with drugs to lower blood pressure and blood cholesterol based on an individual\u2019s absolute cardiovascular risk. Lancet 365:434","journal-title":"Lancet"},{"key":"1_CR50","doi-asserted-by":"publisher","first-page":"S102","DOI":"10.1161\/01.cir.0000437739.71477.ee","volume":"129","author":"MD Jensen","year":"2014","unstructured":"Jensen MD, Ryan DH, Apovian CM et al (2014) 2013 AHA\/ACC\/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation 129:S102","journal-title":"Circulation"},{"key":"1_CR51","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1161\/01.CIR.59.1.8","volume":"59","author":"WB Kannel","year":"1979","unstructured":"Kannel WB, McGee DL (1979a) Diabetes and cardiovascular risk factors: the Framingham study. Circulation 59:8","journal-title":"Circulation"},{"key":"1_CR52","doi-asserted-by":"publisher","first-page":"120","DOI":"10.2337\/diacare.2.2.120","volume":"2","author":"WB Kannel","year":"1979","unstructured":"Kannel WB, McGee DL (1979b) Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care 2:120","journal-title":"Diabetes Care"},{"key":"1_CR53","unstructured":"Kannel WB (1987) Prevalence and clinical aspects of unrecognized myocardial infarction and sudden unexpected death. Circulation 75:II4"},{"key":"1_CR54","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1161\/CIRCULATIONAHA.111.086660","volume":"126","author":"K Kappert","year":"2012","unstructured":"Kappert K, B\u00f6hm M, Schmieder R et al (2012) Impact of sex on cardiovascular outcome in patients at high cardiovascular risk: analysis of the Telmisartan Randomized Assessment Study in ACE-Intolerant Subjects With Cardiovascular Disease (TRANSCEND) and the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial (ONTARGET). Circulation 126:934","journal-title":"Circulation"},{"key":"1_CR55","doi-asserted-by":"publisher","first-page":"e225","DOI":"10.1016\/S0828-282X(09)70506-9","volume":"25","author":"P Kaul","year":"2009","unstructured":"Kaul P, Naylor CD, Armstrong PW et al (2009) Assessment of activity status and survival according to the Canadian Cardiovascular Society angina classification. Can J Cardiol 25:e225","journal-title":"Can J Cardiol"},{"key":"1_CR56","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0140-6736(03)12113-7","volume":"361","author":"EC Keeley","year":"2003","unstructured":"Keeley EC, Boura JA, Grines CL (2003) Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 361:13\u201320","journal-title":"Lancet"},{"key":"1_CR57","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/j.1749-6632.2001.tb03941.x","volume":"947","author":"T Kita","year":"2001","unstructured":"Kita T, Kume N, Minami M et al (2001) Role of oxidized LDL in atherosclerosis. Ann N Y Acad Sci 947:199\u2013205","journal-title":"Ann N Y Acad Sci"},{"key":"1_CR58","doi-asserted-by":"crossref","unstructured":"Kober L, Swedberg K, McMurray JJ, Pfeffer MA, Velazquez EJ, Diaz R, Maggioni AP, Mareev V, Opolski G, Van de Werf F, Zannad F, Ertl G, Solomon SD, Zelenkofske S, Rouleau JL, Leimberger JD, Califf RM (2006) Previously known and newly diagnosed atrial fibrillation: a major risk indicator after a myocardial infarction complicated by heart failure or left ventricular dysfunction. Eur J Heart Fail","DOI":"10.1016\/j.ejheart.2005.11.007"},{"key":"1_CR59","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.jcmg.2009.04.003","volume":"2","author":"DC Lee","year":"2009","unstructured":"Lee DC, Johnson NP (2009) Quantification of absolute myocardial blood flow by magnetic resonance perfusion imaging. JACC Cardiovasc Imaging 2:761","journal-title":"JACC Cardiovasc Imaging"},{"key":"1_CR60","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1161\/CIRCULATIONAHA.107.718585","volume":"117","author":"A-L Levonen","year":"2008","unstructured":"Levonen A-L, Vahakangas E, Koponen JK et al (2008) Antioxidant gene therapy for cardiovascular disease: current status and future perspectives. Circulation 117:2142","journal-title":"Circulation"},{"key":"1_CR61","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","volume":"360","author":"S Lewington","year":"2002","unstructured":"Lewington S, Clarke R, Qizilbash N et al (2002) Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360:1903","journal-title":"Lancet"},{"key":"1_CR62","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1001\/jama.290.17.2271","volume":"290","author":"S Li","year":"2003","unstructured":"Li S, Chen W, Srinivasan SR et al (2003) Childhood cardiovascular risk factors and carotid vascular changes in adulthood: the Bogalusa Heart Study. JAMA 290:2271","journal-title":"JAMA"},{"key":"1_CR63","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/nature01323","volume":"420","author":"P Libby","year":"2002","unstructured":"Libby P (2002) Inflammation in atherosclerosis. Nature 420:868\u2013874","journal-title":"Nature"},{"key":"1_CR64","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1161\/hc0902.104353","volume":"105","author":"P Libby","year":"2002","unstructured":"Libby P, Ridker PM, Maseri A (2002) Inflammation and atherosclerosis. Circulation 105:1135\u20131143","journal-title":"Circulation"},{"key":"1_CR65","doi-asserted-by":"crossref","unstructured":"LloydJones D, Adams RJ, Brown TM et al (2010) Executive summary: heart disease and stroke statistics 2010 update: a report from the American Heart Association. Circulation 121:948","DOI":"10.1161\/CIRCULATIONAHA.109.192666"},{"key":"1_CR66","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1001\/jama.291.18.2204","volume":"291","author":"DM Lloyd-Jones","year":"2004","unstructured":"Lloyd-Jones DM, Nam BH, D\u2019Agostino RB Sr et al (2004) Parental cardiovasculardisease as a risk factor for cardiovascular disease in middle-aged adults: a prospective study of parents and offspring. JAMA 291:2204","journal-title":"JAMA"},{"key":"1_CR67","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1161\/hh0801.089861","volume":"88","author":"J Loscalzo","year":"2001","unstructured":"Loscalzo J (2001) Nitric oxide insufficiency, platelet activation, and arterial thrombosis. Circ Res 88:756\u2013762","journal-title":"Circ Res"},{"key":"1_CR68","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1001\/archinte.158.18.2007","volume":"158","author":"LP Lowe","year":"1998","unstructured":"Lowe LP, Greenland P, Ruth KJ et al (1998) Impact of major cardiovascular disease risk factors, particularly in combination, on 22-year mortality in women and men. Arch Intern Med 158:2007","journal-title":"Arch Intern Med"},{"key":"1_CR69","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/00041552-200201000-00009","volume":"11","author":"FC Luft","year":"2002","unstructured":"Luft FC (2002) Proinflammatory effects of angiotensin II and endothelin: targets for progression of cardiovascular and renal diseases. Curr Opin Nephrol Hypertens 11:59\u201366","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"1_CR70","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1093\/qjmed\/95.4.199","volume":"95","author":"A Makin","year":"2002","unstructured":"Makin A, Silverman SH, Lip GY (2002) Peripheral vascular disease and Virchow\u2019s triad for thrombogenesis. QJM. 95:199\u2013210","journal-title":"QJM."},{"key":"1_CR71","doi-asserted-by":"publisher","first-page":"e183605","DOI":"10.1001\/jamanetworkopen.2018.3605","volume":"1","author":"K Mandsager","year":"2018","unstructured":"Mandsager K, Harb S, Cremer P et al (2018) Association of cardiorespiratory fitness with long-term mortality among adults undergoing exercise treadmill testing. JAMA Netw Open 1:e183605","journal-title":"JAMA Netw Open"},{"key":"1_CR72","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1161\/CIRCULATIONAHA.106.179683","volume":"114","author":"BH Marcus","year":"2006","unstructured":"Marcus BH, Williams DM, Dubbert PM et al (2006) Physical activity intervention studies: what we know and what we need to know: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity); Council on Cardiovascular Disease in the Young; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research. Circulation 114:2739","journal-title":"Circulation"},{"key":"1_CR73","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/s11883-999-0012-z","volume":"1","author":"M Maytin","year":"1999","unstructured":"Maytin M, Leopold J, Loscalzo J (1999) Oxidant stress in the vasculature. Curr Atheroscler Rep 1:156\u2013164","journal-title":"Curr Atheroscler Rep"},{"key":"1_CR74","volume-title":"China public health statistical yearbook 2012","author":"Ministry of Health of People\u2019s Republic of China","year":"2012","unstructured":"Ministry of Health of People\u2019s Republic of China (2012) China public health statistical yearbook 2012. Peking Union Medical College Publishing House, Beijing"},{"key":"1_CR75","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1001\/archinte.161.12.1501","volume":"161","author":"K Miura","year":"2001","unstructured":"Miura K, Daviglus ML, Dyer AR et al (2001) Relationship of blood pressure to 25-year mortality due to coronary heart disease, cardiovascular diseases, and all causes in young adult men: the Chicago Heart Association Detection Project in Industry. Arch Intern Med 161:1501","journal-title":"Arch Intern Med"},{"key":"1_CR76","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1001\/jama.294.24.3117","volume":"294","author":"JM Murabito","year":"2005","unstructured":"Murabito JM, Pencina MJ, Nam BH et al (2005) Sibling cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults. JAMA 294:3117","journal-title":"JAMA"},{"key":"1_CR77","doi-asserted-by":"crossref","unstructured":"National Cholesterol Education Program (NCEP) (2002) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106:3143","DOI":"10.1161\/circ.106.25.3143"},{"key":"1_CR78","first-page":"S1","volume":"39","author":"National Kidney Foundation","year":"2002","unstructured":"National Kidney Foundation (2002) K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39:S1","journal-title":"Am J Kidney Dis"},{"key":"1_CR79","doi-asserted-by":"crossref","unstructured":"Nichols M, Townsend N, Scarborough P, Rayner M (2014) Cardiovascular disease in Europe 2014: epidemiological update. Eur Heart J 35:2950","DOI":"10.1093\/eurheartj\/ehu299"},{"key":"1_CR80","doi-asserted-by":"crossref","unstructured":"Nj\u00f8lstad I, Arnesen E, Lund-Larsen PG (1996) Smoking, serum lipids, blood pressure, and sex differences in myocardial infarction. A 12-year follow-up of the Finnmark Study. Circulation 93:450","DOI":"10.1161\/01.CIR.93.3.450"},{"key":"1_CR81","doi-asserted-by":"crossref","unstructured":"Omran AR (1971) The epidemiologic transition: a theory of the epidemiology of population change. Milbank Q Dec 49: 509\u201338","DOI":"10.2307\/3349375"},{"key":"1_CR82","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.amjcard.2012.12.042","volume":"111","author":"Y Otaki","year":"2013","unstructured":"Otaki Y, Gransar H, Berman DS et al (2013) Impact of family history of coronary artery disease in young individuals (from the CONFIRM registry). Am J Cardiol 111:1081","journal-title":"Am J Cardiol"},{"key":"1_CR83","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/j.amjcard.2005.06.033","volume":"96","author":"ST Palmeri","year":"2005","unstructured":"Palmeri ST, Lowe AM, Sleeper LA, Saucedo JF, Desvigne-Nickens P, Hochman JS (2005) Racial and ethnic differences in the treatment and outcome of cardiogenic shock following acute myocardial infarction. Am J Cardiol 96:1042\u20131049","journal-title":"Am J Cardiol"},{"key":"1_CR84","doi-asserted-by":"publisher","first-page":"245","DOI":"10.7326\/M14-1753","volume":"163","author":"SA Patel","year":"2015","unstructured":"Patel SA, Winkel M, Ali MK et al (2015) Cardiovascular mortality associated with 5 leading risk factors: national and state preventable fractions estimated from survey data. Ann Intern Med 163:245","journal-title":"Ann Intern Med"},{"key":"1_CR85","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.mayocp.2018.01.014","volume":"93","author":"J Patel","year":"2018","unstructured":"Patel J, Al Rifai M, Scheuner MT et al (2018) Basic vs more complex definitions of family history in the prediction of coronary heart disease: the multi-ethnic study of atherosclerosis. Mayo Clin Proc 93:1213","journal-title":"Mayo Clin Proc"},{"key":"1_CR86","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1161\/01.CIR.0000086776.15268.22","volume":"108","author":"B Pitt","year":"2003","unstructured":"Pitt B (2003) Aldosterone blockade in patients with systolic left ventricular dysfunction. Circulation 108:1790\u20131794","journal-title":"Circulation"},{"key":"1_CR87","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1136\/bmj.316.7137.1043","volume":"316","author":"E Prescott","year":"1998","unstructured":"Prescott E, Hippe M, Schnohr P et al (1998) Smoking and risk of myocardial infarction in women and men: longitudinal population study. BMJ 316:1043","journal-title":"BMJ"},{"key":"1_CR88","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1016\/S0006-291X(87)80299-1","volume":"148","author":"MW Radomski","year":"1987","unstructured":"Radomski MW, Palmer RM, Moncada S (1987) The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. Biochem Biophys Res Commun 148:1482\u20131489","journal-title":"Biochem Biophys Res Commun"},{"key":"1_CR89","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1046\/j.1365-2613.2000.00155.x","volume":"81","author":"EW Raines","year":"2000","unstructured":"Raines EW (2000) The extracellular matrix can regulate vascular cell migration, proliferation, and survival: relationships to vascular disease. Int J Exp Pathol 81:173\u2013182","journal-title":"Int J Exp Pathol"},{"key":"1_CR90","doi-asserted-by":"crossref","unstructured":"Raitakari OT, Juonala M, K\u00e4h\u00f6nen M et al (2003) Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. JAMA 290:2277","DOI":"10.1001\/jama.290.17.2277"},{"key":"1_CR91","doi-asserted-by":"crossref","unstructured":"Rauch U, Osende JI, Fuster V et al (2001) Thrombus formation on athero-sclerotic plaques: pathogenesis and clinical consequences. Ann Intern Med 134:224\u2013238","DOI":"10.7326\/0003-4819-134-3-200102060-00014"},{"key":"1_CR92","doi-asserted-by":"crossref","unstructured":"Reaven GM (1988) Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37:1595","DOI":"10.2337\/diab.37.12.1595"},{"key":"1_CR93","doi-asserted-by":"publisher","first-page":"3375","DOI":"10.1073\/pnas.86.9.3375","volume":"86","author":"DD Rees","year":"1989","unstructured":"Rees DD, Palmer RM, Moncada S (1989) Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci USA 86:3375\u20133378","journal-title":"Proc Natl Acad Sci USA"},{"key":"1_CR94","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1476-7120-4-20","volume":"4","author":"A Rehan","year":"2006","unstructured":"Rehan A, Kanwar M, Rosman H, Ahmed S, Ali A, Gardin J, Cohen G (2006) Incidence of post myocardial infarction left ventricular thrombus formation in the era of primary percutaneous intervention and glycoprotein IIb\/IIIa inhibitors. A prospective observational study. Cardiovasc Ultrasound 4:20","journal-title":"Cardiovasc Ultrasound"},{"key":"1_CR95","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1136\/hrt.80.1.98","volume":"80","author":"H Reinecke","year":"1998","unstructured":"Reinecke H, Wichter T, Weyand M (1998) Left ventricular pseudoaneurysm in a patient with Dressler\u2019s syndrome after myocardial infarction. Heart 80:98\u2013100","journal-title":"Heart"},{"key":"1_CR96","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/S0008-6363(98)00321-6","volume":"41","author":"MD Rekhter","year":"1999","unstructured":"Rekhter MD (1999) Collagen synthesis in atherosclerosis: too much and not enough. Cardiovasc Res 41:376\u2013384","journal-title":"Cardiovasc Res"},{"key":"1_CR97","doi-asserted-by":"publisher","first-page":"933","DOI":"10.7326\/0003-4819-130-11-199906010-00018","volume":"130","author":"PM Ridker","year":"1999","unstructured":"Ridker PM (1999) Evaluating novel cardiovascular risk factors: can we better predict heart attacks? Ann Intern Med 130:933","journal-title":"Ann Intern Med"},{"key":"1_CR98","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1001\/jama.285.19.2481","volume":"285","author":"PM Ridker","year":"2001","unstructured":"Ridker PM, Stampfer MJ, Rifai N (2001) Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, lipoprotein(a), and standard cholesterol screening as predictors of peripheral vascular disease. JAMA 285:2481\u20132485","journal-title":"JAMA"},{"key":"1_CR99","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1001\/jama.1996.03530300031036","volume":"275","author":"EB Rimm","year":"1996","unstructured":"Rimm EB, Ascherio A, Giovannucci E et al (1996) Vegetable, fruit, and cereal fiber intake and risk of coronary heart disease among men. JAMA 275:447","journal-title":"JAMA"},{"key":"1_CR100","first-page":"557","volume":"15","author":"A Rivard","year":"2000","unstructured":"Rivard A, Andres V (2000) Vascular smooth muscle cell proliferation in the pathogenesis of atherosclerotic cardiovascular diseases. Histol Histopathol 15:557\u2013571","journal-title":"Histol Histopathol"},{"key":"1_CR101","doi-asserted-by":"crossref","unstructured":"Roger VL, Weston SA, Killian JM et al (2001) Time trends in the prevalence of atherosclerosis: a population based autopsy study. Am J Med 110:267","DOI":"10.1016\/S0002-9343(00)00709-9"},{"key":"1_CR102","doi-asserted-by":"crossref","unstructured":"Roger VL, Weston SA, Gerber Y et al (2010) Trends in incidence, severity, and outcome of hospitalized myocardial infarction. Circulation 121:863","DOI":"10.1161\/CIRCULATIONAHA.109.897249"},{"key":"1_CR103","doi-asserted-by":"crossref","unstructured":"Rogers WJ, Frederick PD, Stoehr E et al (2008) Trends in presenting characteristics and hospital mortality among patients with ST elevation and non ST elevation myocardial infarction in the National Registry of Myocardial Infarction from 1990 to 2006. Am Heart J 156:1026","DOI":"10.1016\/j.ahj.2008.07.030"},{"key":"1_CR104","doi-asserted-by":"crossref","unstructured":"Roncaglioni MC, Santoro L, D\u2019Avanzo B et al (1992) Role of family history in patients with myocardial infarction. An Italian case-control study. GISSI-EFRIM Investigators. Circulation 85:2065","DOI":"10.1161\/01.CIR.85.6.2065"},{"key":"1_CR105","unstructured":"Rosamond W, Flegal K, Furie K et al (2008) Heart disease and stroke statistics 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117:e25"},{"issue":"suppl","key":"1_CR106","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0168-8227(96)80032-5","volume":"30","author":"ME Rosenfeld","year":"1996","unstructured":"Rosenfeld ME (1996) Cellular mechanisms in the development of atherosclerosis. Diabetes Res Clin Pract 30(suppl):1\u201311","journal-title":"Diabetes Res Clin Pract"},{"key":"1_CR107","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jacc.2008.09.032","volume":"53","author":"T Rutledge","year":"2009","unstructured":"Rutledge T, Vaccarino V, Johnson BD et al (2009) Depression and cardiovascular health care costs among women with suspected myocardial ischemia: prospective results from the WISE (Women\u2019s Ischemia Syndrome Evaluation) Study. J Am Coll Cardiol 53:176","journal-title":"J Am Coll Cardiol"},{"key":"1_CR108","doi-asserted-by":"crossref","unstructured":"Sacks FM, Pfeffer MA, Moye LA et al (1996) The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med 335:1001","DOI":"10.1056\/NEJM199610033351401"},{"key":"1_CR109","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1161\/hh2401.101272","volume":"89","author":"U Schonbeck","year":"2001","unstructured":"Schonbeck U, Libby P (2001) CD40 signaling and plaque instability. Circ Res 89:1092\u20131103","journal-title":"Circ Res"},{"key":"1_CR110","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jacc.2006.02.052","volume":"48","author":"BM Scirica","year":"2006","unstructured":"Scirica BM, Sabatine MS, Morrow DA, Gibson CM, Murphy SA, Wiviott SD, Giugliano RP, McCabe CH, Cannon CP, Braunwald E (2006) The role of clopidogrel in early and sustained arterial patency after fibrinolysis for ST-segment elevation myocardial infarction: the ECG CLARITY-TIMI 28 Study. J Am Coll Cardiol 48:37\u201342","journal-title":"J Am Coll Cardiol"},{"key":"1_CR111","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1161\/hc2901.093115","volume":"104","author":"HD Sesso","year":"2001","unstructured":"Sesso HD, Lee IM, Gaziano JM et al (2001) Maternal and paternal history of myocardial infarction and risk of cardiovascular disease in men and women. Circulation 104:393","journal-title":"Circulation"},{"key":"1_CR112","doi-asserted-by":"crossref","unstructured":"Shepherd J, Cobbe SM, Ford I et al (1995) Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med 333:1301","DOI":"10.1056\/NEJM199511163332001"},{"key":"1_CR113","doi-asserted-by":"publisher","first-page":"202","DOI":"10.2337\/diab.41.2.202","volume":"41","author":"DE Singer","year":"1992","unstructured":"Singer DE, Nathan DM, Anderson KM et al (1992) Association of HbA1c with prevalent cardiovascular disease in the original cohort of the Framingham Heart Study. Diabetes 41:202","journal-title":"Diabetes"},{"key":"1_CR114","doi-asserted-by":"publisher","first-page":"10","DOI":"10.7326\/0003-4819-147-1-200707030-00003","volume":"147","author":"I Sipahi","year":"2007","unstructured":"Sipahi I, Tuzcu EM, Wolski KE et al (2007) Beta-blockers and progression of coronary atherosclerosis: pooled analysis of 4 intravascular ultrasonography trials. Ann Intern Med 147:10","journal-title":"Ann Intern Med"},{"key":"1_CR115","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1136\/hrt.2010.210740","volume":"96","author":"S Sivapalaratnam","year":"2010","unstructured":"Sivapalaratnam S, Boekholdt SM, Trip MD et al (2010) Family history of premature coronary heart disease and risk prediction in the EPIC-Norfolk prospective population study. Heart 96:1985","journal-title":"Heart"},{"key":"1_CR116","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1001\/jama.282.21.2012","volume":"282","author":"J Stamler","year":"1999","unstructured":"Stamler J, Stamler R, Neaton JD et al (1999) Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women. JAMA 282:2012","journal-title":"JAMA"},{"key":"1_CR117","unstructured":"The World Bank (2013) Toward a healthy and harmonious life in China: stemming the rising tide of non-communicable diseases. \nhttp:\/\/www.worldbank.org\/content\/dam\/Worldbank\/document\/NCD_report_en.pdf\n\n. Accessed 27 Nov 2013"},{"key":"1_CR118","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1056\/NEJMoa1006992","volume":"364","author":"A Tirosh","year":"2011","unstructured":"Tirosh A, Shai I, Afek A et al (2011) Adolescent BMI trajectory and risk of diabetes versus coronary disease. N Engl J Med 364:1315","journal-title":"N Engl J Med"},{"key":"1_CR119","doi-asserted-by":"crossref","unstructured":"Towfighi A, Zheng L, Ovbiagele B. Sexspecific trends in midlife coronary heart disease risk and prevalence. Arch Intern Med 169:1762","DOI":"10.1001\/archinternmed.2009.318"},{"key":"1_CR120","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1161\/01.ATV.21.1.95","volume":"21","author":"S Tsimikas","year":"2001","unstructured":"Tsimikas S, Palinski W, Witztum JL (2001) Circulating autoantibodies to oxidized LDL correlate with arterial accumulation and depletion of oxidized LDL in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 21:95\u2013100","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1_CR121","doi-asserted-by":"crossref","unstructured":"Twig G, Yaniv G, Levine H et al (2016) Body-mass index in 2.3 million adolescents and cardiovascular death in adulthood. N Engl J Med 374:2430","DOI":"10.1056\/NEJMoa1503840"},{"issue":"Suppl 3","key":"1_CR122","first-page":"S3","volume":"4","author":"JE Udelson","year":"2003","unstructured":"Udelson JE, Patten RD, Konstam MA (2003) New concepts in post-infarction ventricular remodeling. Rev Cardiovasc Med 4(Suppl 3):S3\u2013S12","journal-title":"Rev Cardiovasc Med"},{"key":"1_CR123","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1136\/heart.85.3.342","volume":"85","author":"P Vallance","year":"2001","unstructured":"Vallance P, Chan N (2001) Endothelial function and nitric oxide: clinical relevance. Heart. 85:342\u2013350","journal-title":"Heart."},{"key":"1_CR124","first-page":"635","volume":"12","author":"SO Vargas","year":"1999","unstructured":"Vargas SO, Sampson BA, Schoen FJ (1999) Pathologic detection of early myocardial infarction: a critical review of the evolution and usefulness of modern techniques. Mod Pathol 12:635\u2013645","journal-title":"Mod Pathol"},{"key":"1_CR125","doi-asserted-by":"publisher","first-page":"393","DOI":"10.7326\/0003-4819-142-6-200503150-00005","volume":"142","author":"RS Vasan","year":"2005","unstructured":"Vasan RS, Sullivan LM, Wilson PW et al (2005) Relative importance of borderline and elevated levels of coronary heart disease risk factors. Ann Intern Med 142:393","journal-title":"Ann Intern Med"},{"key":"1_CR126","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0002-9149(98)00336-1","volume":"82","author":"A Volpi","year":"1998","unstructured":"Volpi A, Cavalli A, Santoro L, Negri E (1998) Incidence and prognosis of early primary ventricular fibrillation in acute myocardial infarction\u2014results of the Gruppo Italiano per lo Studio della Sopravvivenza nell\u2019Infarto Miocardico (GISSI-2) database. Am J Cardiol 82:265\u2013271","journal-title":"Am J Cardiol"},{"key":"1_CR127","doi-asserted-by":"crossref","unstructured":"Webber BJ, Seguin PG, Burnett DG et al (2012) Prevalence of and risk factors for autopsy determined atherosclerosis among US service members, 2001-2011. JAMA 308:2577","DOI":"10.1001\/jama.2012.70830"},{"key":"1_CR128","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.1161\/CIRCULATIONAHA.105.551143","volume":"112","author":"HD White","year":"2005","unstructured":"White HD, Aylward PE, Huang Z, Dalby AJ, Weaver WD, Barvik S, Marin-Neto JA, Murin J, Nordlander RO, van Gilst WH, Zannad F, McMurray JJ, Califf RM, Pfeffer MA (2005) Mortality and morbidity remain high despite captopril and\/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT). Circulation 112:3391\u20133399","journal-title":"Circulation"},{"key":"1_CR129","doi-asserted-by":"crossref","unstructured":"Wilhelmsson C, Vedin JA, Elmfeldt D et al (1975) Smoking and myocardial infarction. Lancet 1:415","DOI":"10.1016\/S0140-6736(75)91488-9"},{"key":"1_CR130","doi-asserted-by":"publisher","first-page":"7S","DOI":"10.1093\/ajh\/7.7.7S","volume":"7","author":"PW Wilson","year":"1994","unstructured":"Wilson PW (1994) Established risk factors and coronary artery disease: the Framingham Study. Am J Hypertens 7:7S","journal-title":"Am J Hypertens"},{"key":"1_CR131","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","volume":"97","author":"PW Wilson","year":"1998","unstructured":"Wilson PW, D\u2019Agostino RB, Levy D et al (1998) Prediction of coronary heart disease using risk factor categories. Circulation 97:1837","journal-title":"Circulation"},{"key":"1_CR132","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1161\/CIRCULATIONAHA.108.772962","volume":"118","author":"PW Wilson","year":"2008","unstructured":"Wilson PW, Bozeman SR, Burton TM et al (2008) Prediction of first events of coronary heart disease and stroke with consideration of adiposity. Circulation 118:124","journal-title":"Circulation"},{"key":"1_CR133","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1001\/jama.281.21.1998","volume":"281","author":"A Wolk","year":"1999","unstructured":"Wolk A, Manson JE, Stampfer MJ et al (1999) Long-term intake of dietary fiber and decreased risk of coronary heart disease among women. JAMA 281:1998","journal-title":"JAMA"},{"key":"1_CR134","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1093\/eurheartj\/ehl361","volume":"28","author":"R Wolk","year":"2007","unstructured":"Wolk R, Berger P, Lennon RJ et al (2007) Association between plasma adiponectin levels and unstable coronary syndromes. Eur Heart J 28:292","journal-title":"Eur Heart J"},{"key":"1_CR135","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1093\/eurheartj\/ehi622","volume":"27","author":"CK Wong","year":"2006","unstructured":"Wong CK, Stewart RA, Gao W, French JK, Raffel C, White HD (2006) Prognostic differences between different types of bundle branch block during the early phase of acute myocardial infarction: insights from the Hirulog and Early Reperfusion or Occlusion (HERO)-2 trial. Eur Heart J 27:21\u201328","journal-title":"Eur Heart J"},{"key":"1_CR136","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/eurheartj\/ehr205","volume":"33","author":"ZJ Yang","year":"2012","unstructured":"Yang ZJ, Liu J, Ge JP et al (2012) Prevalence of cardiovascular disease risk factor in the Chinese population: the 2007-2008 China National Diabetes and Metabolic Disorders Study. Eur Heart J 33:213","journal-title":"Eur Heart J"},{"key":"1_CR137","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1016\/S0140-6736(13)61097-1","volume":"381","author":"G Yang","year":"2013","unstructured":"Yang G, Wang Y, Zeng Y et al (2013) Rapid health transition in China, 1990\u20132010: findings from the Global Burden of Disease Study 2010. Lancet 381:1987\u20132015","journal-title":"Lancet"},{"key":"1_CR138","doi-asserted-by":"crossref","unstructured":"Yusuf S, Reddy S, Ounpuu S, Anand S (2001) Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 104:2746","DOI":"10.1161\/hc4601.099487"},{"key":"1_CR139","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","volume":"364","author":"S Yusuf","year":"2004","unstructured":"Yusuf S, Hawken S, Ounpuu S et al (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364:937","journal-title":"Lancet"},{"key":"1_CR140","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/BF03179777","volume":"56","author":"G Zalba","year":"2000","unstructured":"Zalba G, Beaumont J, San Jose G et al (2000) Vascular oxidant stress: molecular mechanisms and pathophysiological implications. J Physiol Biochem 56:57\u201364","journal-title":"J Physiol Biochem"},{"key":"1_CR141","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1056\/NEJM198903163201105","volume":"320","author":"I Zavaroni","year":"1989","unstructured":"Zavaroni I, Bonora E, Pagliara M et al (1989) Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med 320:702","journal-title":"N Engl J Med"}],"container-title":["Advances in Experimental Medicine and Biology","Coronary Artery Disease: Therapeutics and Drug Discovery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-15-2517-9_1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T13:22:45Z","timestamp":1585920165000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-981-15-2517-9_1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9789811525162","9789811525179"],"references-count":141,"URL":"https:\/\/doi.org\/10.1007\/978-981-15-2517-9_1","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"26 March 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}